Technologies

COVID-19 Technology

Title:

Live Attenuated SARS – CoV-2 vaccine

Area:

Life Sciences & Biotechnology, COVID-19 Technology

Focus Area:

Development of vaccine for COVID-19

Developing Agency:

Indian Immunologicals Ltd (IIL) - Griffith University, Australia

Technology Readiness Index:

Commercialized
Website Link :https://indimmune.com/

Brief Description

Description :

A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters. The technology looks promising for developing a vaccine for prophylactic, active, single dose immunization against coronavirus in humans, with an enhanced safety profile. The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization.

Related Technologies